Target intelligence / Profile preview

High mobility group box 3 pseudogene 30 (HMGB3P30)

Target
HMGB3P30
Molecular classification
Pseudogene, Other (not classified as receptor, enzyme, transporter, etc.)
01

Overview

High mobility group box 3 pseudogene 30 (HMGB3P30) is a processed pseudogene related to the high mobility group box 3 (HMGB3) gene family. **Pseudogenes** are genomic DNA sequences similar to normal genes but are non-functional; they arise from gene duplication or retrotransposition followed by disabling mutations[4]. Pseudogenes such as HMGB3P30 generally do not encode proteins and are not classified as enzymes, receptors, transporters, or other conventional therapeutic targets[4]. While some pseudogenes have gained novel regulatory functions (e.g., acting as competitive endogenous RNAs or decoys for microRNAs), there is currently no documented evidence that HMGB3P30 has any such function[3]. Most pseudogenes are considered "genomic fossils" or "junk DNA," though research continues into possible regulatory activities for select pseudogenes. HMGB3P30 is a non-coding, non-functional processed pseudogene; it is not a therapeutic target, not a protein, not implicated in disease or drug interactions, and does not encode a receptor or enzyme. The main concern is confusion due to its similarity in name to functional HMGB gene family members[1][4].

Other names
HMGB3P30
02

Biological functions

No known direct biological function as a protein[4]May have possible *regulatory RNA roles* in rare contexts as with other pseudogenes (see below)[3]
03

Disease associations

None confirmed (pseudogenes in general may be implicated in regulatory network activity, but specific data for HMGB3P30 are lacking)[3][4]

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 30 (HMGB3P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 30 (HMGB3P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call